8-K: Peraso Inc. Faces Nasdaq Bid Price Deficiency

Peraso Inc. received a notice from Nasdaq indicating its common stock is non-compliant with the minimum $1 bid price requirement, with 180 days to regain compliance.

Summary

• Peraso Inc. was notified by Nasdaq on July 21, 2026, that its common stock has not met the minimum bid price requirement of $1 per share for 30 consecutive business days.
• The company has been granted a 180-day period, until January 19, 2027, to regain compliance.
• To comply, the stock's closing bid price must be at least $1 per share for ten consecutive business days within this period.
• If compliance is not achieved, Peraso may be eligible for an additional 180-day period if it meets other listing requirements and commits to a reverse stock split.
• The company is evaluating its options to address the bid price deficiency.
• The 2026 Annual Meeting of Stockholders has been scheduled for September 10, 2026, as a virtual meeting.
• The record date for voting at the annual meeting is July 20, 2026.
• Deadlines for shareholder proposals and director nominations for the 2026 Annual Meeting are August 3, 2026.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing negatively due to the significant risk of delisting from Nasdaq, which could severely impact liquidity and investor perception.

Negatives

• The company's common stock is currently non-compliant with Nasdaq's minimum bid price requirement of $1 per share.
• Failure to regain compliance within 180 days could lead to delisting from the Nasdaq Capital Market.

Risks

• The primary risk is the potential delisting from the Nasdaq Capital Market if the company cannot achieve a closing bid price of at least $1 per share for ten consecutive business days by January 19, 2027.
• If the company requires a second compliance period, it must meet market value of publicly held shares and other initial listing standards, and commit to a reverse stock split, adding execution risk.
• Shareholder confidence may be negatively impacted by the ongoing bid price deficiency and the threat of delisting.

Future Outlook

The company is monitoring its stock price and considering options to regain compliance with Nasdaq's minimum bid price requirement. The 2026 Annual Meeting of Stockholders is scheduled for September 10, 2026.

Management Comments

• The Company is monitoring the closing bid price of its Common Stock and considering its available options in the event the closing bid price of the Common Stock remains below $1 per share.

Industry Context

StockSavvy.ai notes that maintaining compliance with exchange listing rules, particularly minimum bid price requirements, is crucial for investor confidence and liquidity. Companies facing such deficiencies often explore reverse stock splits or other strategic actions to meet these standards.

Stakeholder Impact

• Shareholders face the risk of reduced liquidity and potential value erosion if the stock is delisted from Nasdaq.
• The threat of delisting may negatively impact investor confidence and the company's ability to attract future investment.
• Employees may experience uncertainty regarding the company's future stability and stock-based compensation value.

Next Steps

• Regain compliance with Nasdaq's minimum bid price requirement by January 19, 2027.
• Consider strategic options, potentially including a reverse stock split, to meet listing standards.
• Conduct the 2026 Annual Meeting of Stockholders on September 10, 2026.
• Process shareholder proposals and director nominations by the August 3, 2026 deadline.

Key Dates

Recommendation

The filing indicates a significant risk of delisting due to the bid price deficiency, which is a major concern. However, the company has a 180-day window to rectify the situation, and the possibility of a reverse stock split exists. Given the uncertainty and the potential for recovery, a 'hold' recommendation is appropriate pending further developments or a clear plan to address the compliance issue.

Keywords

Nasdaq compliance, bid price deficiency, delisting risk, annual meeting, stockholder proposals, director nominations, reverse stock split